Talphera Inc (TLPH)

Currency in USD
1.3250
-0.0250(-1.85%)
Closed·
1.2800-0.0450(-3.40%)
·
TLPH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.26001.3600
52 wk Range
0.38621.5700
Key Statistics
Prev. Close
1.35
Open
1.32
Day's Range
1.26-1.36
52 wk Range
0.3862-1.57
Volume
320.39K
Average Volume (3m)
269.52K
1-Year Change
223.2496%
Book Value / Share
0.37
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TLPH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.1667
Upside
+138.99%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Talphera Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 3.1667
(+138.99% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Buy---New Coverage05/06/2026
WestPark Capital
Buy---New Coverage30/04/2026

Talphera Inc Earnings Call Summary for Q1/2026

  • Talphera reported Q1 2026 cash balance of $21.1M, boosted by $4.1M financing tranche, targeting operations through potential 2027 FDA approval.
  • Operating expenses surged 34.5% YoY to $3.9M in Q1 2026, driven by accelerated R&D activities for lead candidate Niyad in CRRT anticoagulation.
  • NEPHRO CRRT study enrollment exceeded 50% milestone; company targets enrollment completion by end-2026 with top-line data following shortly after.
  • Management plans PMA submission in 2026 for potential 2027 FDA approval; stock rose 4.94% aftermarket to $0.8999 on investor optimism.
  • Analysts set price targets of $3-$3.5 but note profitability not expected this year; financing tranche execution remains critical for operations.
Last Updated: 13/05/2026, 22:08
Read Full Transcript

Earnings

Latest Release
13/05/2026
EPS / Forecast
-0.04 / -0.15
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Compare TLPH to Peers and Sector

Metrics to compare
TLPH
Peers
Sector
Relationship
P/E Ratio
−4.8x−7.5x−0.4x
PEG Ratio
−0.12−0.030.00
Price/Book
3.7x2.1x2.6x
Price / LTM Sales
68,767.0x13.3x3.0x
Upside (Analyst Target)
126.4%84.6%53.5%
Fair Value Upside
Unlock−9.1%9.0%Unlock

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company’s lead product candidate, Niyad, is a lyophilized formulation of nafamostat that acts as a regional anticoagulant for infusion into the extracorporeal circuit. It is also developing LTX-608, a lyophilized vial containing nafamostat for IV infusion for disseminated intravascular coagulation, acute respiratory distress syndrome, acute pancreatitis, and an anti-viral treatment; Fedsyra, an ephedrine pre-filled syringe for injection; and a phenylephrine pre-filled syringe for injection. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.

Employees
12

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.00M1.94%1.33M
Other Institutional Investors
43.05M82.94%57.04M
Public Companies & Retail Investors
7.85M15.12%10.40M
Total
51.9M100.00%68.77M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
CorMedix Inc.17.52%9,090,90912,045
AIGH Investment Partners8.98%4,661,5026,176

People Also Watch

4.015000
FWDI
-5.31%
2.7700
GLBS
+1.47%
5.010
AGEN
+0.20%
0.7602
ONCO
-3.98%
1.530
FTEK
-1.29%

FAQ

What Is the Talphera (NASDAQ: TLPH) Share Price Today?

The Talphera stock price today is 1.3250 USD.

What Stock Exchange Does Talphera (TLPH) Trade On?

Talphera is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Talphera?

The stock symbol (also called a 'ticker') for Talphera is "TLPH."

What Is the Current Talphera Market Capitalisation?

As of today, Talphera (NASDAQ: TLPH) market cap is 68.7700M USD.

What Is Talphera's (TLPH) Earnings Per Share (TTM)?

The Talphera EPS is currently -0.2674 (Trailing Twelve Months).

When Is the Next Talphera Earnings Date?

Talphera's next earnings report will be released on 19/08/2026.

Is TLPH a Buy or Sell From a Technical Analyst Perspective?

Based on today's Talphera moving averages and other technical indicators, the daily buy/sell signal for TLPH stock is Strong Buy.

How Many Times Has Talphera Stock Split?

Talphera has split 1 times. (See the TLPH stock split history page for full effective split date and price information.)

How Many Employees Does Talphera Have?

Talphera has 12 employees, based on their latest Companies House report.

What is the current trading status of Talphera (NASDAQ: TLPH)?

As of 19/07/2026, Talphera (TLPH) is trading at a share price of 1.3250 USD, with a previous close of 1.3500 USD. The stock has fluctuated within a day range of 1.2600 USD to 1.3600 USD, while its 52-week range spans from 0.3862 USD to 1.5700 USD.

What Is Talphera (TLPH) Price Target According to Analysts?

The average 12-month price target for Talphera is 3.1667 USD, with a high estimate of 3.5 USD and a low estimate of 3 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +138.99% Upside potential.

What Is the TLPH Premarket Price?

TLPH's last pre-market stock price is 1.2905 USD. The pre-market share volume is 1,540.0000, and the stock has decreased by -0.0595, or -4.4100%.

What Is the TLPH After Hours Price?

TLPH's last after hours stock price is 1.2800 USD, the stock has decreased by -0.0450, or -3.4000%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.